AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharmaceutical Companies

755.666

+7.7451.04%

Number of Gainers:17

Number of Losers:12

Number of Flat:16

PE:- -

High:756.356

Open:753.505

Low:749.555

Close:747.921

Volume:43.52M

Turnover:201.05M

Market Cap:114.75B

Float Cap:111.15B

Loading ...

ASX Midday Sector Update: Healthcare Stocks Climb, Information Technology Sector Down

MT Newswires Live

BUZZ-Australia's CSL can offset tariff impact via US manufacturing deal, UBS says

Mayne Pharma Group Says PBS Approves Reimbursement of Oral Contraceptive Drug

MT Newswires Live

Clinuvel Pharmaceuticals Progresses Preclinical Program Studying Drug Release Profiles

MT Newswires Live

At AU$1.38, Is PolyNovo Limited (ASX:PNV) Worth Looking At Closely?

Simply Wall St.

Don’t believe the hype: why Trump’s pharma tariffs and looming government shutdown won’t hit investors too hard

BRIEF-Anatara Lifesciences Seeks Trading Halt

Anatara Lifesciences - Requests Trading Halt Pending Capital Raising Announcement

THOMSON REUTERS

Asia Morning Call-Global Markets

Did CSL’s (ASX:CSL) Bet on VMX-C001 and FILSPARI’s Guideline Endorsement Just Shift Its Growth Story?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK7508/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":755.666,"timestamp":1760072399855,"preClose":747.92145,"halted":0,"volume":43515793,"delay":0,"changeRate":0.010355,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":7.744568,"latestTime":"10-10 16:00:00 AEDT","open":753.5048,"high":756.3559,"low":749.5553,"amount":201050700,"amplitude":0.009093,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1760310000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1760050800000,1760072400000]],"turnoverRate":0.001558,"increases":13,"decrements":13,"flats":17,"marketCap":114748171758,"floatMarketCap":111152797876.5625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":756.3559,"amplitude":0.009093,"preClose":747.92145,"low":749.5553,"latestPrice":755.666,"volume":43515793,"delay":0,"open":753.5048,"prevYearClose":936.801,"prevWeekClose":755.666,"prevMonthClose":712.826,"prevQuarterClose":712.826,"fiveDayClose":749.725,"twentyDayClose":740.889,"sixtyDayClose":876.9,"secType":"PLATE","market":"AU","turnoverRate":0.001558,"marketCap":114748171758,"floatMarketCap":111152797876.5625,"timestamp":1760072399855,"nameCN":"Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":17,"down":12,"flat":16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571877618","title":"ASX Midday Sector Update: Healthcare Stocks Climb, Information Technology Sector Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2571877618","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571877618?lang=en_us&edition=fundamental","pubTime":"2025-09-29 11:22","pubTimestamp":1759116153,"startTime":"0","endTime":"0","summary":"Healthcare stocks climbed almost 2% at midday Monday, rebounding after a decline on Friday in the wake of a new pharmaceutical tariff regime announced by the US. Investors are waiting for the Australian central bank's policy meeting on Tuesday. It is expected to hold rates steady.Clinuvel Pharmaceuticals , whose shares rose over 2%, said it progressed a preclinical program evaluating various drug release profiles with sustained-release liquid drug formulations, with the program for the first formulations expected to be completed in the second half of 2026.On the flip side, the information technology sector shed 0.6%.NOVONIX , whose shares were up over 17%, said it delivered the first industrial-grade mass production sample of synthetic graphite produced via its continuous graphitization furnace technology to a North American value-added carbon processor.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7084","CUV.AU","BK7508","III","BK7067","BK4581","BK4134","HCSG","BK4137","LABU","NVX.AU","XLV","BK4588","XBI","BK4585"],"gpt_icon":0},{"id":"2571252872","title":"BUZZ-Australia's CSL can offset tariff impact via US manufacturing deal, UBS says","url":"https://stock-news.laohu8.com/highlight/detail?id=2571252872","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571252872?lang=en_us&edition=fundamental","pubTime":"2025-09-29 11:01","pubTimestamp":1759114875,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's CSL can offset tariff impact via US manufacturing deal, UBS says** CSL CSL.AX up 2.7% at A$199.5, set for strongest trading session since July 22** Biotech major tracks gains on ASX Healthcare sub-index .AXHJ, which is up 1.9%** UBS estimates $1.2 bln unmitigated EBIT hit from Trump's 100% tariffs on patented drugs** Broker sees potential company-wide tariff exemption tied to accelerating U.S. fractionation facility with investment of $1.5-2 bln** Expects limited scope to offset costs via higher U.S. drug pricing, more likely alternative is redirection of co's Behring and Seqirus sales outside the U.S. but at lower pricing** Sales redirection option to reduce CSL's tariff EBIT impact to $700 mln** Brokerage rates stock \"buy\", PT A$300** CSL down 29.2% YTD, including day's moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nL6N3VG05J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK7508","BK7511","CSL.AU","BK7501","LFPI","BK7067"],"gpt_icon":0},{"id":"2571719138","title":"Mayne Pharma Group Says PBS Approves Reimbursement of Oral Contraceptive Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2571719138","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571719138?lang=en_us&edition=fundamental","pubTime":"2025-09-29 09:51","pubTimestamp":1759110713,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said the Australian Pharmaceutical Benefits Scheme  approved the reimbursement of oral contraceptive Nextstellis, according to a Monday filing with the Australian bourse.Nextstellis will be listed on the PBS General Schedule from October, the filing said.Shares rose nearly 1% in morning trade on Monday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7508","XAO.AU","BK7096","XKO.AU","XJO.AU","PBS"],"gpt_icon":0},{"id":"2571875573","title":"Clinuvel Pharmaceuticals Progresses Preclinical Program Studying Drug Release Profiles","url":"https://stock-news.laohu8.com/highlight/detail?id=2571875573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571875573?lang=en_us&edition=fundamental","pubTime":"2025-09-29 08:26","pubTimestamp":1759105587,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  said it progressed a preclinical program evaluating various drug release profiles with sustained-release liquid drug formulations, with the program for the first formulations expected to be completed in the second half of 2026, according to a Monday Australian bourse filing.The formulations the firm is reviewing could facilitate flexible dosing by adjusting the injection volume for the delivery of peptides to infants, children, and adults according to body weight.If the technology is confirmed in vivo, the formulations would serve as a platform to deliver various peptides, with an initial focus on melanocortins.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUV.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2571263801","title":"At AU$1.38, Is PolyNovo Limited (ASX:PNV) Worth Looking At Closely?","url":"https://stock-news.laohu8.com/highlight/detail?id=2571263801","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571263801?lang=en_us&edition=fundamental","pubTime":"2025-09-29 07:40","pubTimestamp":1759102819,"startTime":"0","endTime":"0","summary":"While PolyNovo Limited ( ASX:PNV ) might not have the largest market cap around , it led the ASX gainers with a...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/at-au138-is-polynovo-limited-asxpnv-worth-looking-at-closely","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/at-au138-is-polynovo-limited-asxpnv-worth-looking-at-closely","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","PNV.AU","BK7126"],"gpt_icon":0},{"id":"2571755708","title":"Don’t believe the hype: why Trump’s pharma tariffs and looming government shutdown won’t hit investors too hard","url":"https://stock-news.laohu8.com/highlight/detail?id=2571755708","media":"Switzer","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571755708?lang=en_us&edition=fundamental","pubTime":"2025-09-29 07:27","pubTimestamp":1759102031,"startTime":"0","endTime":"0","summary":"This week you’ll see loud headlines about new US tariffs aimed at parts of the pharmaceutical industry, and fresh brinkmanship in Washington that could end in a government shutdown. Noise levels are high. Signal, less so. ","market":"hk","thumbnail":"https://switzer.com.au/wp-content/uploads/nik-lego-man-surprise-shock-unsplash.jpg","type":0,"news_type":0,"thumbnails":["https://switzer.com.au/wp-content/uploads/nik-lego-man-surprise-shock-unsplash.jpg"],"rights":{"source":"switzer_stock","url":"https://switzer.com.au/the-experts/luke-hopewell/dont-believe-the-hype-why-trumps-pharma-tariffs-and-looming-government-shutdown-wont-hit-investors-too-hard/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://switzer.com.au/the-experts/luke-hopewell/dont-believe-the-hype-why-trumps-pharma-tariffs-and-looming-government-shutdown-wont-hit-investors-too-hard/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"switzer_stock","symbols":["BK7112","BK7511","AMP.AU","BK7501","CSL.AU","BK7508","BK7067","XJO.AU","XAO.AU","XKO.AU"],"gpt_icon":0},{"id":"2571582047","title":"BRIEF-Anatara Lifesciences Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2571582047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571582047?lang=en_us&edition=fundamental","pubTime":"2025-09-29 07:04","pubTimestamp":1759100654,"startTime":"0","endTime":"0","summary":"BRIEF-Anatara Lifesciences Seeks Trading HaltSept 29 (Reuters) - Anatara Lifesciences Ltd ANR.AX:REQUESTS TRADING HALT PENDING CAPITAL RAISING ANNOUNCEMENTFurther company coverage: ANR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250928:nFWN3VE0P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","ANR.AU"],"gpt_icon":0},{"id":"2571820429","title":"Anatara Lifesciences - Requests Trading Halt Pending Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2571820429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571820429?lang=en_us&edition=fundamental","pubTime":"2025-09-29 07:02","pubTimestamp":1759100534,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250928:nFWN3VE0P6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","ANR.AU"],"gpt_icon":0},{"id":"2571829268","title":"Asia Morning Call-Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2571829268","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571829268?lang=en_us&edition=fundamental","pubTime":"2025-09-29 03:05","pubTimestamp":1759086351,"startTime":"0","endTime":"0","summary":"Asia Morning Call-Global MarketsSept 29 (Reuters) - Stock MarketsNet ChngStock MarketsNet ChngS&P/ASX 200**8787.7014.70NZX 50**13,111.73-42.06DJIA46,247.29299.97NIKKEI**45,354.99-399.94Nasdaq22,484.07","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250928:nL4N3TV02Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"gpt_icon":0},{"id":"2570816756","title":"Did CSL’s (ASX:CSL) Bet on VMX-C001 and FILSPARI’s Guideline Endorsement Just Shift Its Growth Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2570816756","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570816756?lang=en_us&edition=fundamental","pubTime":"2025-09-28 04:57","pubTimestamp":1759006655,"startTime":"0","endTime":"0","summary":"VarmX recently announced a strategic collaboration with CSL to advance the development of VMX-C001, a new treatment designed to rapidly restore blood coagulation in patients on FXa direct oral anticoagulants who require urgent surgery or experience severe bleeding; this deal includes CSL fully funding global late-stage trials and providing VarmX shareholders with an upfront payment of US$117 million for an exclusive option to acquire the company, with further milestone and sales-based...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-csls-asxcsl-bet-on-vmx-c001-and-filsparis-guideline-endo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/did-csls-asxcsl-bet-on-vmx-c001-and-filsparis-guideline-endo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","LU0728928796.USD","BK7511","LU1169589451.USD","BK7067","SGXZ23171101.USD","CSL.AU","BK4086","BK7508","CSL","LU1169590202.USD","SG9999004303.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":110,"code":"91000000","status":"200"}]}}